Clinical Trials Browser

Phase 2 × Omacor × 90 days × Clear all

NCT06195306 2026-05-20

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Phase 2 Recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04268134 2026-05-06

ALTA

Phase 2 Completed

77 enrolled 13 charts

Breast Neoplasms